As of 2025-07-06, the EV/EBITDA ratio of Vir Biotechnology Inc (VIR) is -0.79. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VIR's latest enterprise value is 474.31 mil USD. VIR's TTM EBITDA according to its financial statements is -600.70 mil USD. Dividing these 2 quantities gives us the above VIR EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.1x - 14.5x | 13.2x |
| Forward P/E multiples | 13.5x - 16.9x | 15.0x |
| Fair Price | (56.77) - (61.11) | (59.18) |
| Upside | -1149.3% - -1229.7% | -1193.9% |
| Date | EV/EBITDA |
| 2025-07-03 | -0.79 |
| 2025-07-02 | -0.79 |
| 2025-07-01 | -0.72 |
| 2025-06-30 | -0.70 |
| 2025-06-27 | -0.73 |
| 2025-06-26 | -0.77 |
| 2025-06-25 | -0.74 |
| 2025-06-24 | -0.76 |
| 2025-06-23 | -0.71 |
| 2025-06-20 | -0.75 |
| 2025-06-18 | -0.74 |
| 2025-06-17 | -0.72 |
| 2025-06-16 | -0.75 |
| 2025-06-13 | -0.75 |
| 2025-06-12 | -0.75 |
| 2025-06-11 | -0.75 |
| 2025-06-10 | -0.79 |
| 2025-06-09 | -0.79 |
| 2025-06-06 | -0.80 |
| 2025-06-05 | -0.73 |
| 2025-06-04 | -0.76 |
| 2025-06-03 | -0.75 |
| 2025-06-02 | -0.71 |
| 2025-05-30 | -0.68 |
| 2025-05-29 | -0.74 |
| 2025-05-28 | -0.64 |
| 2025-05-27 | -0.62 |
| 2025-05-23 | -0.58 |
| 2025-05-22 | -0.61 |
| 2025-05-21 | -0.58 |
| 2025-05-20 | -0.63 |
| 2025-05-19 | -0.61 |
| 2025-05-16 | -0.60 |
| 2025-05-15 | -0.59 |
| 2025-05-14 | -0.58 |
| 2025-05-13 | -0.63 |
| 2025-05-12 | -0.76 |
| 2025-05-09 | -0.71 |
| 2025-05-08 | -0.79 |
| 2025-05-07 | -0.84 |
| 2025-05-06 | -0.84 |
| 2025-05-05 | -0.96 |
| 2025-05-02 | -0.96 |
| 2025-05-01 | -0.94 |
| 2025-04-30 | -0.95 |
| 2025-04-29 | -0.92 |
| 2025-04-28 | -0.95 |
| 2025-04-25 | -0.95 |
| 2025-04-24 | -0.99 |
| 2025-04-23 | -0.92 |